11.05.2014 Views

OUCOM DEPARTMENT OF FAMILY MEDICINE 2010-2011 AN

OUCOM DEPARTMENT OF FAMILY MEDICINE 2010-2011 AN

OUCOM DEPARTMENT OF FAMILY MEDICINE 2010-2011 AN

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>OUCOM</strong> <strong>DEPARTMENT</strong> <strong>OF</strong> <strong>FAMILY</strong> <strong>MEDICINE</strong><br />

<strong>2010</strong>-<strong>2011</strong> <strong>AN</strong>NUAL REPORT<br />

Principal Investigator<br />

(Sub-Investigator)<br />

Benencia, Fabian<br />

[Walkowski,<br />

Stevan-33%]<br />

[Goodrum, Kenneth-<br />

33%]<br />

Borchard, John<br />

[Boyd, Sara-15%]<br />

Clark, Brian<br />

[Howell, John-40%]<br />

Thomas, James-10%]<br />

[Walkowski,Stevan-<br />

10%]<br />

Schwartz, Frank<br />

[Shubrook, Jay-<br />

50%]<br />

Schwartz, Frank<br />

[Shubrook, Jay-<br />

50%]<br />

<strong>2010</strong>-<strong>2011</strong> ACTIVE EXTERNAL RESEARCH GR<strong>AN</strong>TS<br />

Title Agency Period<br />

Total Award Received in<br />

to COM <strong>2010</strong>-<strong>2011</strong><br />

Mechanisms of American<br />

09/10-08/11 $50,000 $50,000<br />

Immune<br />

Osteopathic<br />

Modulation by Association<br />

Osteopathic<br />

Manipulative<br />

Treatment-<br />

Induced Cytokine<br />

Release<br />

State Rural<br />

Health<br />

Association<br />

Technical<br />

Assistance<br />

Neurophysiologic<br />

effects of<br />

manipulative<br />

treatment of<br />

individuals with<br />

sub-acute back<br />

pain<br />

Clinical Trial<br />

Clinical Trial<br />

National Rural<br />

Health<br />

Association<br />

Osteopathic<br />

Heritage<br />

Foundation<br />

University of<br />

South Florida<br />

Amylin<br />

Pharmaceuticals,<br />

Inc.<br />

Shubrook, Jay Clinical Trial Sanofi-aventis<br />

U.S., LLC<br />

Shubrook, Jay Clinical Trial Takeda Global<br />

R&D Center, Inc.<br />

Shubrook, Jay A Pilot Study of Sanofi-aventis<br />

[Schwartz, Frank- Intensive<br />

U.S., LLC<br />

20%]<br />

Regimen as a<br />

Primary<br />

Treatment of New<br />

Onset of Type 2<br />

DM (INSPIRE<br />

Diabetes)<br />

Shubrook, Jay<br />

[Schwartz, Frank-<br />

20%]<br />

Shubrook, Jay<br />

[Schwartz, Frank-<br />

20%]<br />

Shubrook, Jay<br />

[Schwartz, Frank-<br />

20%]<br />

Shubrook, Jay<br />

[Schwartz, Frank-<br />

20%]<br />

Clinical Trial<br />

Clinical Trial<br />

Clinical Trial<br />

Clinical Trial<br />

Sanofi-aventis<br />

U.S., LLC<br />

Sanofi-aventis<br />

U.S., LLC<br />

Sanofi-aventis<br />

U.S., LLC<br />

Hoffman-La<br />

Roche, Inc.<br />

12/10-11/11 $8,075 $8,075<br />

01/10-01/11 $76,384 $0<br />

10/08-10/10 $2,564 $820<br />

09/07-11/11 $11,220 $1,800<br />

09/09-09/10 $1,200 $1,200<br />

03/10-03/11 $5,431 $3,525<br />

06/10-06/12 $679,095 $308,302<br />

11/08-09/10 $40,389 $0<br />

11/08-11/10 $57,380 $10,655<br />

11/09-11/10 $26,280 $14,640<br />

09/08-09/10 $11,554 $3,287<br />

Page 31

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!